Arecor Therapeutics (LON:AREC) Stock Price Up 7.9% – Still a Buy?

Arecor Therapeutics plc (LON:AREC) shares were up 7.9% during trading on Wednesday . The stock traded as high as GBX 67.45 and last traded at GBX 67.45. Approximately 5,000 shares changed hands during trading, a decline of 70% from the average daily volume of 16,600 shares. The stock had previously closed at GBX 62.50.

Arecor Therapeutics Stock Up 7.9%

The company has a debt-to-equity ratio of 6.06, a quick ratio of 6.24 and a current ratio of 2.05. The company has a market cap of £25.47 million, a price-to-earnings ratio of -2.93 and a beta of -0.18. The business has a 50-day simple moving average of GBX 75.73 and a 200-day simple moving average of GBX 76.92.

About Arecor Therapeutics

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.